Efficacy of Oral Sodium Tungstate (200 mg/Day) on Weight Loss in Subjects With Grade I-II Obesity

Trial Profile

Efficacy of Oral Sodium Tungstate (200 mg/Day) on Weight Loss in Subjects With Grade I-II Obesity

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Jul 2016

At a glance

  • Drugs Sodium tungstate (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Acronyms TROTA-1
  • Most Recent Events

    • 02 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Oct 2009 Results presented at the 2009 Annual Meeting of the North American Association for the Study of Obesity (NAASO 2009).
    • 23 Jul 2008 The expected completion date for this trial has been extended from May 2008 to May 2009, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top